ID: ALA1208930

Max Phase: Preclinical

Molecular Formula: C19H17NO3

Molecular Weight: 307.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(NCCc1ccc(O)c(O)c1)c1ccc2ccccc2c1

Standard InChI:  InChI=1S/C19H17NO3/c21-17-8-5-13(11-18(17)22)9-10-20-19(23)16-7-6-14-3-1-2-4-15(14)12-16/h1-8,11-12,21-22H,9-10H2,(H,20,23)

Standard InChI Key:  RZFNRCLEGKSYBA-UHFFFAOYSA-N

Associated Targets(Human)

Dynamin-1 215 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 307.35Molecular Weight (Monoisotopic): 307.1208AlogP: 3.22#Rotatable Bonds: 4
Polar Surface Area: 69.56Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.29CX Basic pKa: CX LogP: 3.44CX LogD: 3.44
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.65Np Likeness Score: -0.23

References

1. Lee S, Jung KY, Park J, Cho JH, Kim YC, Chang S..  (2010)  Synthesis of potent chemical inhibitors of dynamin GTPase.,  20  (16): [PMID:20621477] [10.1016/j.bmcl.2010.06.092]

Source